Axa S.A. Vera Therapeutics, Inc. Transaction History
Axa S.A.
- $29.5 Billion
- Q1 2025
A detailed history of Axa S.A. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Axa S.A. holds 245,565 shares of VERA stock, worth $4.74 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
245,565
Previous 245,879
0.13%
Holding current value
$4.74 Million
Previous $10.4 Million
43.28%
% of portfolio
0.02%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$110 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$91.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$64.5 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$57.2 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$56.4 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $522M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...